Cognitive functioning and work-related outcomes of non-central nervous system cancer survivors: protocol for a systematic review with meta-analysis
- PMID: 35820744
- PMCID: PMC9277407
- DOI: 10.1136/bmjopen-2021-060300
Cognitive functioning and work-related outcomes of non-central nervous system cancer survivors: protocol for a systematic review with meta-analysis
Abstract
Introduction: In recent years, growing attention has been given to the study of the impact of cancer-related cognitive impairment (CRCI) in working non-central nervous system (CNS) cancer survivors. Available literature has shown that working cancer survivors identify cognitive problems at work as very problematic and worrisome. Some reviews have discussed the association between CRCI and work-related outcomes; however, none to date have investigated this association through comprehensive systematic review with meta-analysis. Hence, this work will comprehensively summarise existing evidence from quantitative studies assessing the relationship between CRCI and work-related outcomes of adult non-CNS cancer survivors at working age.
Methods and analysis: The systematic review procedures and its report will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Electronic searches in the databases Web of Science, Scopus, PubMed, ProQuest, PsycINFO and CINAHL, complemented by a manual search of other relevant articles, will be performed from 2000 onwards to identify relevant publications. Two independent reviewers will assess studies for inclusion and extract data from each article using a standardised form. Studies eligible for inclusion must be quantitative, contain adult non-CNS cancer survivors with CRCI, and a measure of cognitive functioning and work-related outcomes. To assess risk of bias, the Joanna Briggs Institute Critical Appraisal Tool Studies checklists will be independently used by the two researchers. Synthesis of the included articles will be conducted using a narrative method and through meta-analysis. Meta-analysis will be reported via correlation for the association between CRCI and work-related outcomes. The cumulative evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation system.
Ethics and dissemination: Ethics approval is not required since individual patient data will not be collected. The findings will be published in a peer-review indexed journal, presented at scientific meetings and included in a chapter of a Doctoral thesis.
Prospero registration number: CRD42020165458.
Keywords: adult oncology; delirium & cognitive disorders; occupational & industrial medicine; protocols & guidelines; statistics & research methods.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review.BMJ Open. 2018 Jan 27;8(1):e017578. doi: 10.1136/bmjopen-2017-017578. BMJ Open. 2018. PMID: 29374660 Free PMC article.
-
Effective non-pharmacological interventions for cancer related cognitive impairment in adults (excluding central nervous system or head and neck cancer): systematic review and meta-analysis.Eur J Phys Rehabil Med. 2022 Apr;58(2):258-270. doi: 10.23736/S1973-9087.21.06898-2. Epub 2021 Sep 9. Eur J Phys Rehabil Med. 2022. PMID: 34498828 Free PMC article.
-
Digital game-based interventions for cognitive training in healthy adults and adults with cognitive impairment: protocol for a two-part systematic review and meta-analysis.BMJ Open. 2023 May 4;13(5):e071059. doi: 10.1136/bmjopen-2022-071059. BMJ Open. 2023. PMID: 37142320 Free PMC article.
-
Managing cognitive impairment following stroke: protocol for a systematic review of non-randomised controlled studies of psychological interventions.BMJ Open. 2018 Jan 10;8(1):e019001. doi: 10.1136/bmjopen-2017-019001. BMJ Open. 2018. PMID: 29326188 Free PMC article.
-
Cancer-related cognitive impairment: updates to treatment, the need for more evidence, and impact on quality of life-a narrative review.Ann Palliat Med. 2024 Sep;13(5):1265-1280. doi: 10.21037/apm-24-70. Epub 2024 Sep 9. Ann Palliat Med. 2024. PMID: 39260437 Review.
Cited by
-
[Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy].An Sist Sanit Navar. 2023 Aug 16;46(2):e1040. doi: 10.23938/ASSN.1040. An Sist Sanit Navar. 2023. PMID: 37594060 Free PMC article. Spanish.
References
-
- Mayo SJ, Lustberg M, M Dhillon H, et al. . Cancer-Related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC neurological complications Study Group. Support Care Cancer 2021;29:2821–40. 10.1007/s00520-020-05860-9 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical